Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of chemotherapy plus gefitinib, followed by chemotherapy, radiation therapy, and gefitinib for head and neck cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gefitinib (Gefitinib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED